About Tollovid
Tollovid develops diagnostic tools that can save lives when used to find cancers early. The Company's cutting-edge and patented Tollovid proprietary cancer-screening technology uses peripheral blood analysis to look for biochemical changes in blood mononuclear cells and plasma in order to examine the impact of cancer on the immune system. The tmb 1 and tmb 2 cancer screening tests they created internally have been granted a ce mark in europe. They recently acquired provista Diagnostics, Inc., a medical diagnostics company based in the United States, to obtain the rights to its certified lab in Alpharetta, georgia, which is currently performing prc covid testing and Provista's proprietary Videssa breast cancer blood test, which is in the commercial-stage.